Reinhard Zeidler

Epstein‐Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival.

J. Banchereau, W. Hammerschmidt, B. Kempkes, 1996, The EMBO journal.

Profile identification of disease-associated humoral antigens using AMIDA, a novel proteomics-based technology

B. Wollenberg, W. Hammerschmidt, B. Mack, 2004, Cellular and Molecular Life Sciences CMLS.

Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells.

W. Hammerschmidt, D. Pich, R. Zeidler, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Downregulation of TAP1 in B lymphocytes by cellular and Epstein-Barr virus-encoded interleukin-10.

R. Tampé, W. Hammerschmidt, G. Eissner, 1997, Blood.

5ʹ-Ectonucleotidase CD73/NT5E supports EGFR-mediated invasion of HPV-negative head and neck carcinoma cells

O. Gires, C. Reichel, M. Canis, 2023, Journal of Biomedical Science.

Ep-CAM--a marker for the detection of disseminated tumor cells in patients suffering from SCCHN.

E. Kastenbauer, B. Wollenberg, R. Zeidler, 1999, Anticancer research.

SARS-CoV-2 and Epstein–Barr Virus-like Particles Associate and Fuse with Extracellular Vesicles in Virus Neutralization Tests

W. Hammerschmidt, D. Pich, Stephan Becker, 2023, Biomedicines.

Light-Induced Transformation of Virus-Like Particles on TiO2

A. Stierle, W. Hammerschmidt, M. Schwartzkopf, 2024, ACS applied materials & interfaces.